10 employees
It is a biopharmaceutical company which develop new bioactive molecules for the treatment of neurodegenerative diseases.
2007
$2.7M
from 3 investors over 3 rounds
Alz Protect raised $2.7M on June 11, 2014
Investors: Nord France Amorçage and FINOVAM
Alz Protect raised undisclosed on November 1, 2008
Investors: FINORPA